Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Bayer

Tracked across 40 events · 755 articles · First seen Oct 06, 2025 · Last active Sep 22, 2026

Sentiment
17
Attention
8
Events
40
Relationships
20
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
3 20
Business
Impact: Bayer Group is consolidating its U.S. glyphosate business into Ruveon LLC to optimize operations and enhance focus on innovation and profitability within its Crop Science division.
Jul 01, 2026 · 6 articles
6 30
Business
Impact: Bayer has agreed to a proposed $7.25 billion settlement to resolve thousands of lawsuits alleging its Roundup weedkiller causes cancer, aiming to reduce litigation uncertainty and financial strain. This settlement is crucial for Bayer's financial survival and ability to continue selling Roundup in agricultural markets.
Feb 17, 2026 · 10 articles
4 70
Business
Impact: Bayer completed the acquisition of TherapeuticsMD, strengthening its pharmaceutical pipeline and ophthalmology expertise. This acquisition gives Bayer full rights to PER-001 intravitreal implant.
Jun 17, 2026 · 7 articles
2 10
Business
Impact: Bayer>>> appointed Matt Reinhardt>>> as President of its Radiology business, aiming to drive innovation and growth in a key division. This strategic move is expected to strengthen Bayer>>>'s position in medical imaging solutions.
Jun 09, 2026 · 6 articles
2 10
Business
Impact: Bayer announced leadership changes within its Consumer Health division to accelerate growth and strengthen commercial execution, aiming to enhance its 'Road to Billions' strategy.
Jun 08, 2026 · 7 articles
2 15
Business
Impact: Bayer forms its first academic medical center alliance for clinical trials, aiming to accelerate drug development and expand patient access, which could enhance its pipeline and reputation.
Jul 07, 2026 · 7 articles
7 80
Regulatory
Impact: Bayer is the primary beneficiary; the ruling shields it from thousands of failure-to-warn lawsuits, reducing litigation risk and boosting investor confidence. Shares rose ~18%.
Jun 25, 2026 · 133 articles
4 70
Regulatory
Impact: Manufacturer of elinzanetant; the approval expands its market and potential revenue, though public funding in Canada is pending.
Aug 17, 2026 · 6 articles
4 25
Regulatory
Bayer's Bayer — Monsanto unit appeared before the Missouri Circuit Court in St. Louis on September 14, 2026, seeking final approval of a $7.25 billion class settlement intended to resolve tens of thousands of U.S.…
Impact: Bayer is the central party seeking court approval of the $7.25 billion settlement to resolve roughly 65,000 Roundup claims; approval would remove a major legal overhang and support its turnaround, while rejection would prolong litigation and weigh on its shares.
Sep 11, 2026 · 6 articles
4 45
Regulatory
Bayer announced on September 17, 2026 that the U.S. United States — Food and Drug Administration approved Kerendia (finerenone) for the treatment of adult patients with chronic kidney disease associated with type 1 diabetes. The…
Impact: Bayer received FDA approval for Kerendia in a new type 1 diabetes CKD indication, its third U.S. indication for the drug, strengthening its pharmaceutical portfolio and long-term revenue prospects.
Sep 17, 2026 · 8 articles
4 20
Business
Apollo Global Management announced on September 16, 2026 that Apollo-managed funds and affiliates closed a 3 billion euro capital solution for Bayer, a transaction first announced on July 10, 2026. KKR & Co. joined Apollo…
Impact: Bayer secured and closed 3 billion euros in equity capital for its LARC business while retaining majority ownership and full operational control. The capital strengthens Bayer's balance sheet amid bond maturities and litigation costs.
Sep 16, 2026 · 6 articles
2 20
Business
Bayer and Neste finalized a commercial agreement on September 9, 2026, to jointly scale Bayer's newgold winter canola as a feedstock for renewable diesel and sustainable aviation fuel. The deal follows a memorandum of understanding…
Impact: Bayer is the lead party, commercializing its newgold winter canola seed brand and expanding its biofuels crop portfolio. The agreement supports its Crop Science growth narrative and positions it in the expanding renewable feedstock market.
Sep 09, 2026 · 6 articles
4 70
Business
Impact: Bayer is partnering with Natur-Tec India Private Limited to jointly develop biodegradable and compostable seedling cups, contributing its crop science capabilities to advance sustainable agriculture.
Jun 16, 2026 · 7 articles
2 5
Business
Grunenthal, a privately held German pharmaceutical company focused on pain management, announced an agreement with Bayer to acquire the cancer treatment Stivarga (regorafenib) for up to 375 million euros. Stivarga is an oral multikinase inhibitor…
Impact: Bayer is the seller of Stivarga, divesting a non-core oncology asset for up to 375 million euros. The transaction modestly streamlines its portfolio and provides a small cash inflow.
Sep 21, 2026 · 6 articles
6 20
Business
Impact: Bayer invested in Bicara Therapeutics' $180 million financing, supporting the development of deupirfenidone.
Jul 02, 2026 · 6 articles
2 30
Business
Impact: Bayer's investment arm Bayer led the round, aligning with Bayer's sustainability objectives and potentially enhancing its agricultural technology portfolio.
Jul 14, 2026 · 6 articles
1 35
Business
Impact: Mentioned as player; limited direct impact.
Jul 08, 2026 · 6 articles
6 0
Regulatory
Impact: Bayer is reviewing its options regarding the United States — Medicaid pilot program, having missed the application deadline.
Apr 20, 2026 · 6 articles
4 10
Business
Impact: Bayer is a pharmaceutical company that participates in the OpenFold consortium, benefiting from access to AI-enabled tools for drug discovery.
Jun 10, 2026 · 9 articles
4 40
Domestic
Impact: Bayer is a partner supporting the broader AgriConnect initiative led by the World Bank Group.
Jun 04, 2026 · 6 articles
4 20
Regulatory
Impact: Bayer supported Gilead's appeal as an amicus, benefiting from the ruling that limits drugmakers' liability.
Aug 03, 2026 · 6 articles
6 0
Tech
Impact: Bayer>>> is mentioned as a competitor with its ARPI drug Nubeqa, indicating potential market competition with Johnson & Johnson>>>'s Apalutamide>>>.
May 31, 2026 · 6 articles
6 20
Business
Impact: Bayer leverages Databricks for AI and data analytics, benefiting from platform advancements.
Jul 17, 2026 · 12 articles
2 10
Tech
Impact: Bayer is mentioned as the acquirer of Algeta and Xofigo, providing background on Oncoinvent's founders. No direct impact on Bayer.
Aug 11, 2026 · 6 articles
1 0
Tech
Market Logic Software announced on September 16, 2026 the general availability of DeepSights Radar, a new agentic AI capability within its DeepSights market intelligence platform. DeepSights Radar autonomously monitors, analyzes and synthesizes developments across selected…
Impact: Bayer is named as a Market Logic customer, a passive reference with no material effect on its business or valuation.
Sep 16, 2026 · 6 articles
2 5
Business
Iambic Therapeutics, a San Diego-based drug developer backed by Nvidia and the Qatar Investment Authority, filed for a US initial public offering on Monday, September 21, 2026, aiming to list on the Nasdaq under the…
Impact: Listed as an existing partnership partner of Iambic, with no new action in this event.
Sep 21, 2026 · 6 articles
8 -5
International
Impact: Bayer fell, minor impact.
Jul 28, 2026 · 318 articles
7 0
International
Jan 17, 2026 · 6 articles
6 0
Regulatory
Apr 02, 2026 · 8 articles
4 0
Tech
Apr 01, 2026 · 6 articles
+ 10 more events View on Dashboard
ERGEN INTELLIGENCE
Track Bayer live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.